Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Commercialization phase - Jan 2023 to December 2025

<< Previous

Bullboard Posts

Next >>

Comment by jmm1228on May 05, 2022 9:51am

138 Views

Post# 34658280

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Commercialization phase - Jan 2023 to December 2025

How will TLT carry on the establishment of a full scale market ing/manufacturing/distribution operation
with the assets presently at hand?

What is the best way to establish such expediently given the current lack of these vital capabilities and the long dwell time to establish. The learning curve is steep!

What entities believe they are best positioned to handle the matter?

Stay tuned, something will happen, the status quo won't carry this off.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario